Respiratorius AB (FRA:HF00) Accounts Payable: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HF00 Respiratorius AB FRA:HF00
34 GF Score
Price €0.19
View Full Analysis

What is Respiratorius AB Accounts Payable?

Respiratorius AB FRA:HF00 -0.80% 34 Accounts Payable is €0.00 Mil as of Jun. 2026. GuruFocus rates FRA:HF00 with a GF Score™ of 34/100.

Respiratorius AB's Accounts Payable for the quarter that ended in Jun. 2026 was €0.00 Mil.

Respiratorius AB's quarterly Accounts Payable declined from Dec. 2025 (€0.10 Mil) to Mar. 2026 (€0.00 Mil) but then stayed the same from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€0.00 Mil).

Respiratorius AB's annual Accounts Payable increased from Dec. 2023 (€0.03 Mil) to Dec. 2024 (€0.05 Mil) and increased from Dec. 2024 (€0.05 Mil) to Dec. 2025 (€0.10 Mil).

Respiratorius AB Accounts Payable Related Terms

Respiratorius AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Accounts Payable Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.04 0.03 0.05 0.10

Respiratorius AB Quarterly Data
Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.10 0.00 0.00
FRA:HF00
34GF Score
Respiratorius AB FRA:HF00
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.00 Mil mean?
Respiratorius AB (FRA:HF00) has a Accounts Payable of €0.00 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Respiratorius AB and its competitors.
Is Respiratorius AB's Accounts Payable too high?
Respiratorius AB's current Accounts Payable is €0.00 Mil. Overall, Respiratorius AB has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's Accounts Payable compare to VRTX and REGN?
Respiratorius AB's Accounts Payable of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Respiratorius AB and its competitors. Respiratorius AB's current Accounts Payable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (FRA:HF00) has a current Accounts Payable of €0.00 Mil. The current Accounts Payable is €0.00 Mil. Respiratorius AB's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Respiratorius AB (FRA:HF00), the current Accounts Payable is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Other Exchanges RESP:Sweden
Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
34GF Score

Get the complete analysis for FRA:HF00

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price